ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
ReShape Lifesciences Inc

ReShape Lifesciences Inc (RSLS)

4.75
0.30
(6.74%)
終値: 12月27日 6:00AM
4.75
0.00
( 0.00% )
取引時間後: 6:44AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
4.75
買値
4.50
売値
4.95
出来高
11,399
4.40 日の範囲 4.75
4.09 52 週間の範囲 29.00
時価総額
前日終値
4.45
始値
4.40
最終取引時間
07:15:34
財務取引量
US$ 51,586
VWAP
4.5255
平均取引量 (3 か月)
92,713
発行済株式数
712,680
配当利回り
-
PER
-0.30
1 株当たり利益 (EPS)
-15.98
歳入
8.68M
純利益
-11.39M

ReShape Lifesciences Inc について

Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, a... Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, and ReShapeCare, a virtual coaching program delivered through an app. 詳細を表示

セクター
Surgical,med Instr,apparatus
業界
Surgical,med Instr,apparatus
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
ReShape Lifesciences Inc is listed in the Surgical,med Instr,apparatus sector of the ナスダック市場 with ticker RSLS. The last closing price for ReShape Lifesciences was US$4.45. Over the last year, ReShape Lifesciences shares have traded in a share price range of US$ 4.09 to US$ 29.00.

ReShape Lifesciences currently has 712,680 shares in issue. The market capitalisation of ReShape Lifesciences is US$3.17 million. ReShape Lifesciences has a price to earnings ratio (PE ratio) of -0.30.

RSLS 最新ニュース

ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update

Revenue Increased 16.6% in the Third Quarter of 2024 Over the Second Quarter, Representing the Third Sequential Quarter of Growth, and 6.4% Compared to the Same Period in 2023 Significant...

ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update

IRVINE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it...

ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX

IRVINE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Health...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.255.555555555564.54.754.26185754.39490269CS
4-0.99-17.24738675965.745.944.09292974.91697575CS
12-0.67-12.36162361625.427.24.09927135.61033192CS
26-6.328-57.122224228211.07816.59964.0971213210.82196669CS
52-12.36-72.238457042717.11294.09197552213.69093349CS
156-5737.25-99.9172762104574257714.091515202160.29053879CS
260-748.38-99.369298793753.13275504.0914274803160.3628477CS

RSLS - Frequently Asked Questions (FAQ)

What is the current ReShape Lifesciences share price?
The current share price of ReShape Lifesciences is US$ 4.75
How many ReShape Lifesciences shares are in issue?
ReShape Lifesciences has 712,680 shares in issue
What is the market cap of ReShape Lifesciences?
The market capitalisation of ReShape Lifesciences is USD 3.17M
What is the 1 year trading range for ReShape Lifesciences share price?
ReShape Lifesciences has traded in the range of US$ 4.09 to US$ 29.00 during the past year
What is the PE ratio of ReShape Lifesciences?
The price to earnings ratio of ReShape Lifesciences is -0.3
What is the cash to sales ratio of ReShape Lifesciences?
The cash to sales ratio of ReShape Lifesciences is 0.39
What is the reporting currency for ReShape Lifesciences?
ReShape Lifesciences reports financial results in USD
What is the latest annual turnover for ReShape Lifesciences?
The latest annual turnover of ReShape Lifesciences is USD 8.68M
What is the latest annual profit for ReShape Lifesciences?
The latest annual profit of ReShape Lifesciences is USD -11.39M
What is the registered address of ReShape Lifesciences?
The registered address for ReShape Lifesciences is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the ReShape Lifesciences website address?
The website address for ReShape Lifesciences is www.reshapelifesciences.com
Which industry sector does ReShape Lifesciences operate in?
ReShape Lifesciences operates in the SURGICAL,MED INSTR,APPARATUS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
EVAXEvaxion Biotech AS
US$ 1.57
(85.58%)
6.69M
RVSNRail Vision Ltd
US$ 1.15
(48.66%)
3.14M
LIDRAEye Inc
US$ 1.8495
(44.49%)
1.47M
KITTNauticus Robotics Inc
US$ 2.5207
(41.61%)
4.2M
CRKNCrown Electrokinetics Corporation
US$ 0.1801
(36.75%)
25.53M
VIRXViracta Therapeutics Inc
US$ 0.199
(-16.03%)
299.8k
XELBXcel Brands Inc
US$ 0.45
(-13.28%)
33.27k
LKCOLuokung Technology Corporation
US$ 1.63
(-12.37%)
16.78k
RAYRaytech Holding Ltd
US$ 1.39
(-12.03%)
10.88k
CTCXCarmell Corporation
US$ 0.288
(-10.56%)
143.71k
CRKNCrown Electrokinetics Corporation
US$ 0.1823
(38.42%)
25.53M
OMEXOdyssey Marine Exploration Inc
US$ 0.614
(27.78%)
9.33M
EVAXEvaxion Biotech AS
US$ 1.57
(85.58%)
6.69M
KITTNauticus Robotics Inc
US$ 2.5207
(41.61%)
4.2M
XTIAXTI Aerospace Inc
US$ 0.0401
(0.25%)
3.87M

RSLS Discussion

投稿を表示

最近閲覧した銘柄